{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:25:57Z","timestamp":1772270757448,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":36,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd009950.pub2","type":"reference-entry","created":{"date-parts":[[2013,10,20]],"date-time":"2013-10-20T12:58:14Z","timestamp":1382273894000},"source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological treatment for pain in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1002","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewan D","family":"McNicol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,20]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD009950.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","article-title":"Gabapentin for the treatment of pain in Guillain-Barr\u00e9 syndrome: a double-blinded, placebo-controlled, crossover study","volume":"95","author":"Pandey","year":"2002","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1002\/14651858.CD009950.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","article-title":"The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barr\u00e9 syndrome patients in the intensive care unit","volume":"101","author":"Pandey","year":"2005","journal-title":"Anesthesia and Analgesia"},{"issue":"10","key":"10.1002\/14651858.CD009950.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00415-006-0515-2","article-title":"Determination of pain and response to methylprednisolone in Guillain-Barr\u00e9 syndrome","volume":"254","author":"Ruts","year":"2007","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009950.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007632-200202150-00011","article-title":"Glycosphingolipid antibodies in serum in patients with sciatica","volume":"27","author":"Brisby","year":"2002","journal-title":"Spine"},{"issue":"1","key":"10.1002\/14651858.CD009950.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2004.09.021","article-title":"Impairment in Guillain-Barr\u00e9 syndrome during the first 2 years after onset: a prospective study","volume":"227","author":"Forsberg","year":"2004","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD009950.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barr\u00e9 syndrome: a randomized trial","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.410280222","article-title":"Capsaicin for the treatment of pain in Guillain-Barr\u00e9 syndrome","volume":"28","author":"Morgenlander","year":"1990","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009950.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000086477","article-title":"Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barr\u00e9 syndrome","volume":"53","author":"Odaka","year":"2005","journal-title":"European Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009950.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00003246-200003000-00009","article-title":"Carbamezapine for pain management in Guillain-Barr\u00e9 syndrome patients in the intensive care unit","volume":"28","author":"Tripathi","year":"2000","journal-title":"Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009950.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bja\/aer260","article-title":"Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch","volume":"107","author":"Anand","year":"2011","journal-title":"British Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD009950.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury","year":"1990","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD009950.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/0269216304pm845ra","article-title":"Gabapentin in the treatment of neuropathic pain","volume":"18","author":"Bennett","year":"2004","journal-title":"Palliative Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009950.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.55.4.552","article-title":"Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy","volume":"55","author":"Berciano","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"The Journal of Pain"},{"issue":"7109","key":"10.1002\/14651858.CD009950.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD009950.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-199111000-00030","article-title":"Opioid analgesics and the burning pain of Guillain-Barr\u00e9 syndrome","volume":"75","author":"Ennis","year":"1991","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"key":"10.1002\/14651858.CD009950.pub2-BIB18|cit18","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"9497","key":"10.1002\/14651858.CD009950.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD009950.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barr\u00e9 syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12016-010-8213-3","article-title":"Guillain-Barr\u00e9 syndrome-a classical autoimmune disease triggered by infection or vaccination","volume":"42","author":"Israeli","year":"2012","journal-title":"Clinical Reviews in Allergy and Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1002\/14651858.CD009950.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain-establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD009950.pub2-BIB24|cit24","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD009950.pub2-BIB25|cit25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.48.2.328","article-title":"Pain in Guillain-Barr\u00e9 syndrome","volume":"48","author":"Moulin","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3959(94)90068-X","article-title":"Pain in the Guillain-Barr\u00e9 syndrome: a clinical review","volume":"59","author":"Pentland","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD009950.pub2-BIB28|cit28","unstructured":"Peterson K McDonagh M Thakurta S Dana T Roberts C Chou R Drug class review: cyclo-oxygenase (COX)-2 inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs): final update 4 report www.ncbi.nlm.nih.gov\/books\/NBK53955\/"},{"key":"10.1002\/14651858.CD009950.pub2-BIB29|cit29","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"16","key":"10.1002\/14651858.CD009950.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barr\u00e9 syndrome: a long-term follow-up study","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD009950.pub2-BIB31|cit31","first-page":"21","article-title":"Antidepressants as analgesics: an overview of central and peripheral mechanisms of action","volume":"26","author":"Sawynok","year":"2001","journal-title":"Journal of Psychiatry and Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD009950.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pmr.2005.12.006","article-title":"Antidepressant and anticonvulsant medication for chronic pain","volume":"17","author":"Sullivan","year":"2006","journal-title":"Physical Medicine and Rehabilitation Clinics of North America"},{"issue":"9404","key":"10.1002\/14651858.CD009950.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome:randomised trial","volume":"363","author":"Koningsveld","year":"2004","journal-title":"Lancet"},{"issue":"9168","key":"10.1002\/14651858.CD009950.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD009950.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00101-008-1408-9","article-title":"Opioids in anesthesia","volume":"57","author":"Z\u00f6llner","year":"2008","journal-title":"Anaesthesist"},{"issue":"7","key":"10.1002\/14651858.CD009950.pub2-BIB36|cit36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009950","article-title":"Pharmacological treatment for pain in Guillain-Barr\u00e9 syndrome","author":"Liu","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009950.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009950.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:38:41Z","timestamp":1628548721000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009950.pub2"}},"subtitle":[],"editor":[{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,20]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009950.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD009950.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,10,20]]}}}